Abstract: The invention provides pharmaceutical compositions comprising cyclosporine dissolved in a semifluorinated alkane for use in the treatment of uveitis.

Abstract: The present invention relates to an antiparasitic composition comprising an antiparasitic agent and a semifluorinated alkane.

Abstract: The present disclosure relates to topical sunscreen formulations comprising a semifluorinated alkane and a metal oxide selected from titanium dioxide, zinc oxide or mixtures thereof.

Abstract: The invention provides ophthalmic compositions comprising about 0.1 % (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.

Abstract: The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease and provides for treatment methods thereof. The invention further provides kits comprising such compositions.

Abstract: The invention provides ophthalmic composition comprising cyclosporine and a semifluorinated alkane for use in the treatment of ocular allergy and any symptoms associated thereto.

Abstract: The present disclosure is in the field of ointments which can be useful for the treatment of diseases or conditions associated with lipid barrier damage of the skin. The ointment comprises a semifluorinated alkane and a solid thickening agent, e.g., a wax, a triglyceride, cetyl alcohol, cetyl palmitate, or tetradecanol.

Abstract: The present disclosure relates to topical sunscreen formulations comprising a semifluorinated alkane and a metal oxide selected from titanium dioxide, zinc oxide or mixtures thereof.

Abstract: The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.

Abstract: A fuel cell membrane is described comprising at least one sulfonated aromatic polyether copolymer comprising a poly-arylen-ether-ketone (PEK) moiety or sulfonated derivatives thereof, deriving from spiro-bis-indane or 4,4?-(hexafluoroisopropylidene)diphenol (BPAF), and an arylene-sulfone, or an arylene-ketone or sulfonated derivative thereof; said copolymer having the following formula (1): wherein Ar1 has formula, wherein X is spiro-bis-indanile (SBI) (b) or BPAF (c) having formulas: and wherein Y is H or SO3H, and Ar2 has formula wherein W is CO or SO2, and Y is H or SO3H, wherein Z is OH or Cl; and wherein at least one between Ar1 or Ar2 comprise at least one sulfonic group; and wherein n is an integer comprised between 2 and 50. A method for the production of such membrane is also described.

Abstract: A fuel cell membrane is described comprising at least one sulfonated aromatic polyether copolymer comprising a poly-arylen-ether-ketone (PEK) moiety or sulfonated derivatives thereof, deriving from spiro-bis-indane or 4,4?-(hexafluoroisopropylidene)diphenol (BPAF), and an arylene-sulfone, or an arylene-ketone or sulfonated derivative thereof; said copolymer having the following formula (1): wherein Ar1 has formula, wherein X is spiro-bis-indanile (SBI) (b) or BPAF (c) having formulas: and wherein Y is H or SO3H, and Ar2 has formula wherein W is CO or SO2, and Y is H or SO3H, wherein Z is OH or Cl; and wherein at least one between Ar1 or Ar2 comprise at least one sulfonic group; and wherein n is an integer comprised between 2 and 50. A method for the production of such membrane is also described.